Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
ANI Pharmaceuticals, Inc. (ANIP) had Debt to Equity Ratio of 1.02 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$266.04M |
|
$24.71M |
|
$100.16M |
|
$165.89M |
|
$225.58M |
|
$40.46M |
|
$-3.36M |
|
$37.10M |
|
$37.10M |
|
$24.71M |
|
$24.71M |
|
$24.71M |
|
$24.71M |
|
$40.46M |
|
$60.10M |
|
21.16M |
|
21.91M |
|
$1.09 |
|
$1.05 |
|
| Balance Sheet Financials | |
$825.43M |
|
$73.22M |
|
$668.68M |
|
$1.49B |
|
$283.65M |
|
$589.16M |
|
$613.25M |
|
$896.90M |
|
$597.21M |
|
$84.88M |
|
$597.21M |
|
22.97M |
|
| Cash Flow Statement Financials | |
$115.04M |
|
$-14.38M |
|
$-26.26M |
|
$285.62M |
|
$360.25M |
|
$74.63M |
|
$21.60M |
|
-- |
|
$0.00M |
|
| Fundamental Metrics & Ratios | |
2.91 |
|
-- |
|
-- |
|
0.50 |
|
|
Debt to Equity Ratio |
1.02 |
62.35% |
|
15.21% |
|
15.21% |
|
-- |
|
13.94% |
|
9.29% |
|
$105.92M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.70 |
|
0.97 |
|
92.85 |
|
4.14% |
|
29.11% |
|
1.65% |
|
2.08% |
|
$26.00 |
|
$4.83 |
|
$5.25 |
|